JNJ-42756493
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for JNJ-42756493, covering 2014-12-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma [Phase 1]